Will “Big Three Positive” (HBsAg, HBeAg, and anti-HBc positive) inevitably progress to cirrhosis?

Mar 07, 2022 Source: Cainiu Health

Dr. Li Yi

Introduction

Not all individuals with “Big Three-Positive” (i.e., positive HBsAg, HBeAg, and anti-HBc) status will inevitably progress to cirrhosis. “Big Three-Positive” indicates hepatitis B virus (HBV) infection; if the infection persists for more than six months, it is generally classified as chronic HBV infection. Chronic HBV infection may manifest as “Big Three-Positive,” “Small Three-Positive” (i.e., positive HBsAg, anti-HBe, and anti-HBc), or “Small Two-Positive” (i.e., positive HBsAg and anti-HBc), among other patterns. Regardless of the serological profile, all such cases warrant close clinical attention.

“Big Three-Positive” and “Small Three-Positive” are colloquial terms used in hepatitis testing to describe patterns in which three specific hepatitis B virus (HBV) antigens and antibodies test positive. Does “Big Three-Positive” status inevitably progress to cirrhosis? Below, we address this question.

Does “Big Three-Positive” status inevitably lead to cirrhosis?

No, not all individuals with “Big Three-Positive” status will inevitably develop cirrhosis.

“Big Three-Positive” indicates active HBV infection. If the infection persists for more than six months, it is generally classified as chronic hepatitis B infection. Chronic HBV infection may manifest as “Big Three-Positive,” “Small Three-Positive,” or even “Small Two-Positive.” Regardless of the serological pattern, each scenario warrants clinical attention.

Some patients experience recurrent episodes of hepatitis; others may progress to cirrhosis or even hepatocellular carcinoma (HCC). However, disease progression is strongly influenced by individual factors—including overall health status and lifestyle habits. Notably, some patients may never develop active hepatitis, cirrhosis, or HCC throughout their lifetime.

Therefore, individuals with chronic HBV infection must adopt and maintain healthy lifestyle habits. Additionally, regular clinical assessment of disease status is essential. Timely and effective antiviral treatment during the hepatitis phase can significantly reduce the risk of developing cirrhosis.

The above addresses the question of whether “Big Three-Positive” status inevitably leads to cirrhosis. We hope this information is helpful to you.

View All

How to treat drug-induced liver cirrhosis

The core treatment for drug-induced cirrhosis includes immediate discontinuation of the causative medication, hepatoprotective drug therapy, symptomatic management of complications, nutritional support, and adjunctive interventions targeting the underlying cause. Once diagnosed, patients should promptly seek care at a reputable hospital's gastroenterology or hepatology department to avoid delays in treatment. Immediate discontinuation of the causative medication: this is the most critical initial step.